Fetuin-A/AHSG Rekombinanter Antikörper
Fetuin-A/AHSG Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1E4
Kat-Nr. : 80793-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
80793-1-PBS bindet in WB, Indirect ELISA Fetuin-A/AHSG und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | Fetuin-A/AHSG fusion protein Ag9853 |
Vollständiger Name | alpha-2-HS-glycoprotein |
Berechnetes Molekulargewicht | 367 aa, 39 kDa |
Beobachtetes Molekulargewicht | 58 kDa |
GenBank-Zugangsnummer | BC048198 |
Gene symbol | Fetuin-A |
Gene ID (NCBI) | 197 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Reinigung |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Fetuin-A, also named as Alpha2-HS glycoprotein (AHSG), is a member of cystatin superfamily of protease inhibitors. It is a highly expressed glycoprotein in various fetal tissues whereas it is mainly expressed by the liver in adults. Fetuin A, an extracellular inhibitor of transforming growth factor β, is a profibrogenic stimulus in liver disease. Circulating fetuin-A may be a beneficial serum biomarker in the detection of liver and vascular fibrosis progression in patients with non-alcoholic fatty liver disease. It is also involved in several functions, such as endocytosis, brain development and the formation of bone tissue. Fetuin-A exerts its effects on the cardiovascular system by two different mechanisms. On the one hand it inhibits ins signaling and induces ins resistance contributing to the onset of atherosclerosis and on the other hand it inhibits calcium deposition and protects from vascular calcification.